Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

Hormones significantly affect skin health, with vitamin D playing a key role.

Hair cortisol levels can effectively indicate long-term hormone activity.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Men with early balding often have hormone levels similar to women with polycystic ovary syndrome.

A 73-year-old woman's unusual hair loss and growth led to the discovery of a rare condition causing too much testosterone, which improved after her ovaries were removed.

Surgical removal of an adrenal tumor resolved hormonal issues in a young woman.

Removing the ovarian tumor improved the woman's hormonal symptoms.

Hormonal treatments can effectively improve hidradenitis suppurativa symptoms.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Some steroid-induced health issues in rodents improved after stopping treatment, but hair loss and eye problems did not.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Oral contraceptives and antiandrogens are effective for treating hirsutism, with antiandrogens being the most effective.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Young men with early baldness may have lower Luteinizing Hormone levels due to higher dihydrotestosterone, possibly from certain drugs or gland disorders.

New methods help diagnose skin conditions caused by too much male hormone in women, like acne, hair loss, and excess hair growth.

Hair growth pathways are a promising and simpler method for detecting chronic stress.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

A woman with non-classic CAH had unusual heavy periods and high hormone levels, improved with treatment.